Filing Details
- Accession Number:
- 0001209191-17-065970
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-15 16:44:46
- Reporting Period:
- 2017-12-13
- Accepted Time:
- 2017-12-15 16:44:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1598646 | Minerva Neurosciences Inc. | NERV | Pharmaceutical Preparations (2834) | 260784194 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1610384 | Remy Luthringer | C/O Minerva Neurosciences, Inc. 1601 Trapelo Road, Suite 286 Waltham MA 02451 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-12-14 | 18,750 | $0.00 | 18,750 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-12-14 | 2,194 | $5.85 | 16,556 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Acquisiton | 2017-12-13 | 350,000 | $0.00 | 350,000 | $6.10 |
| Common Stock | Restricted Stock Unit | Disposition | 2017-12-14 | 18,750 | $0.00 | 18,750 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 350,000 | 2027-12-13 | No | 4 | A | Direct | |
| 56,250 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 926,604 | Indirect | By Wint2felden Holding SA |
Footnotes
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock
- Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stockin connection with the settlement of the vested portion of RSUs pursuant to the terms of that certain RSU Agreement between the Reporting Person and the Issuer, as reflected in this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.80 to $5.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
- This option vests as to 25% of the shares on December 13, 2018 and then in quarterly installments over 3 years thereafter.
- Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date.
Billionaire Hedge Funds
